FDA Approved: EXFORGE HCT — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, through an original application for the treatment of hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge HCT (amlodipine/valsartan/hydrochlorothiazide)

Snippet

ORIG AP for EXFORGE HCT (AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE)